Patents by Inventor Imtiaz A. Chaudry

Imtiaz A. Chaudry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of mometasone furoate for treating upper airway diseases
    Patent number: 6956030
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: January 22, 2004
    Date of Patent: October 18, 2005
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent number: 6949532
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: January 22, 2004
    Date of Patent: September 27, 2005
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Stabilized antihistamine syrup
    Patent number: 6939550
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: September 6, 2005
    Assignee: Schering Corporation
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Use of mometasone furoate for treating upper airway diseases
    Publication number: 20040223920
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Application
    Filed: January 22, 2004
    Publication date: November 11, 2004
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Bronchodilating compositions and methods
    Patent number: 6814953
    Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: November 9, 2004
    Assignee: Dey L.P.
    Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry
  • Use of mometasone furoate for treating airway passage and lung diseases
    Publication number: 20040152683
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Application
    Filed: January 22, 2004
    Publication date: August 5, 2004
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Use of mometasone furoate for treating upper airway diseases
    Patent number: 6723713
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: April 20, 2004
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Inhalation compositions, methods of use thereof, and process for preparation of same
    Publication number: 20040023935
    Abstract: Bronchodilating concentrates and diluted compositions, methods of use thereof, and processes for making the concentrates and diluted compositions, are provided. The compositions are intended for administration as a nebulized aerosol. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
    Type: Application
    Filed: August 2, 2002
    Publication date: February 5, 2004
    Applicant: Dey, L.P.
    Inventors: Partha S. Banerjee, Ramana R. Malladi, Imtiaz A. Chaudry
  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent number: 6677322
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: January 13, 2004
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent number: 6677323
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: January 13, 2004
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Bronchodilating compositions and methods
    Patent number: 6667344
    Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: December 23, 2003
    Assignee: Dey, L.P.
    Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry
  • Use of mometasone furoate for treating airway passage and lung diseases
    Publication number: 20030216365
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Application
    Filed: April 30, 2003
    Publication date: November 20, 2003
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Stabilized antihistamine syrup
    Publication number: 20030152595
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Application
    Filed: November 15, 2002
    Publication date: August 14, 2003
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Formoterol/steroid bronchodilating compositions and methods of use thereof
    Publication number: 20030055026
    Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof, and a steroidal anti-inflammatory agent. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchocon-strictive disorders using the compositions provided herein are also provided.
    Type: Application
    Filed: June 22, 2001
    Publication date: March 20, 2003
    Applicant: Dey L.P.
    Inventors: Partha S. Banerjee, Imtiaz A. Chaudry
  • Stabilized antihistamine syrup
    Patent number: 6514520
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: February 4, 2003
    Assignee: Schering Corporation
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Non-chlorofluorocarbon aerosol formulations
    Patent number: 6503482
    Abstract: Aerosol formulations substantially free of chlorofluorocarbons, for oral and/or nasal administration, are described. The formulations comprise 1,1,1,2-tetrafluoroethane, a medicament, optionally an excipient and optionally a surfactant. Methods of treatment using the formulations also are described.
    Type: Grant
    Filed: December 9, 1993
    Date of Patent: January 7, 2003
    Assignee: Schering Corporation
    Inventors: Julianne Fassberg, Joel A. Sequeira, Imtiaz A. Chaudry, Michael Kopcha
  • Formoterol/steroid bronchodilating compositions and methods of use thereof
    Publication number: 20020183293
    Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof, and a steroidal anti-inflammatory agent. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
    Type: Application
    Filed: May 13, 2002
    Publication date: December 5, 2002
    Inventors: Partha S. Banerjee, Imtiaz A. Chaudry
  • Bronchodilating compositions and methods
    Publication number: 20020151597
    Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
    Type: Application
    Filed: June 22, 2001
    Publication date: October 17, 2002
    Applicant: Dey L.P.
    Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry
  • Bronchodilating compositions and methods
    Publication number: 20020151598
    Abstract: Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
    Type: Application
    Filed: May 3, 2002
    Publication date: October 17, 2002
    Inventors: Partha S. Banerjee, Stephen Pham, Samuel O. Akapo, Imtiaz A. Chaudry
  • Stabilized antihistamine syrup
    Publication number: 20020132805
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Application
    Filed: July 5, 2001
    Publication date: September 19, 2002
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira